Global HIV/AIDS Drugs Market | Movements by Trend Analysis, Growth Status

October 14, 2020
Ankit2369

The global HIV/AIDS drugs market is likely to derive growth form the increasing prevalence of the disease across the world. According to a report published by Fortune Business Insights, titled “HIV/AIDS Drugs Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 25,314.0 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 40,675.0 Mn by 2026, thereby exhibiting a CAGR of 6.1% in the forecast period

HIV DRUGS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026

  1. Introduction

1.1.    Research Scope

1.2.    Market Segmentation

1.3.    Research Methodology

1.4.    Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.    Market Drivers

3.2.    Market Restraints

3.3.    Market Opportunities

  1. Key Insights

4.1.    Epidemiology of HIV/AIDS by Key Countries

4.2.    Overview of Pipeline Analysis

4.3.    Regulatory Scenario by Key Countries

4.4.    Pricing Analysis

4.5.    Key Strategies Employed by Market Leaders in Various Regions

4.6.    Overview of New Product Launches

  1. Global HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026

5.1.    Key Findings / Summary

5.2.    Market Analysis, Insights and Forecast – By Drug Class

5.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

5.2.2. Integrase Inhibitors

5.2.3. Combination HIV Medicines

5.2.4. Others

5.3.    Market Analysis, Insights and Forecast – By Distribution Channel

5.3.1. Hospital Pharmacies

5.3.2. Retail Pharmacies

5.3.3. Online Pharmacies

5.3.4. Others

5.4.    Market Analysis, Insights and Forecast – By Region

5.4.1. North America

5.4.2. Europe

5.4.3. Asia Pacific

5.4.4. Rest of World

  1. North America HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026

6.1.    Key Findings / Summary

6.2.    Market Analysis – By Drug Class

6.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

6.2.2. Integrase Inhibitors

6.2.3. Combination HIV Medicines

6.2.4. Others

6.3.    Market Analysis – By Distribution Channel

6.3.1. Hospital Pharmacies

6.3.2. Retail Pharmacies

6.3.3. Online Pharmacies

6.3.4. Others

6.4.    Market Analysis – By Country

6.4.1. U.S.

6.4.2. Canada

  1. Europe HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026

7.1.    Key Findings / Summary

7.2.    Market Analysis – By Drug Class

7.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

7.2.2. Integrase Inhibitors

7.2.3. Combination HIV Medicines

7.2.4. Others

7.3.    Market Analysis – By Distribution Channel

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Online Pharmacies

7.3.4. Others

7.4.    Market Analysis – By Country/ Sub-Region

7.4.1. U.K.

7.4.2. Germany

7.4.3. France

7.4.4. Spain

7.4.5. Italy

7.4.6. Scandinavia

7.4.7. Rest of Europe

  1. Asia Pacific HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026

8.1.    Key Findings / Summary

8.2.    Market Analysis – By Drug Class

8.2.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

8.2.2. Integrase Inhibitors

8.2.3. Combination HIV Medicines

8.2.4. Others

8.3.    Market Analysis – By Distribution Channel

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.3.4. Others

8.4.    Market Analysis – By Country/ Sub-Region

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. Southeast Asia

8.4.6. Rest of Asia Pacific

Continued…

Sedation In ICU Setting Market

Botulinum Toxin Market

Next-generation Sequencing Market

Article Tags:
Article Categories:
BUSINESS